(Q73203933)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10571251%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Reaction of metformin with dicarbonyl compounds. Possible implication in the inhibition of advanced glycation end product formation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10571251%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

0 references

D Ruggiero-Lopez

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10571251%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

M Lecomte

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10571251%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

G Moinet

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10571251%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

G Patereau

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10571251%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

M Lagarde

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10571251%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

N Wiernsperger

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10571251%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

language of work or name

English

0 references

publication date

1 December 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10571251%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

published in

Biochemical Pharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10571251%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

58

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10571251%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10571251%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

1765-1773

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10571251%20AND%20SRC:MED&resulttype=core&format=json

Mechanism of protein modification by glyoxal and glycolaldehyde, reactive intermediates of the Maillard reaction

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900263-4

Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900263-4

New biomarkers of Maillard reaction damage to proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900263-4

Formation of reactive intermediates from Amadori compounds under physiological conditions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900263-4

Mechanism of autoxidative glycosylation: identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900263-4

Hydroxyl radical production and autoxidative glycosylation. Glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and ageing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900263-4

The advanced glycation end product, Nepsilon-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900263-4

Glyoxalase System in Clinical Diabetes Mellitus and Correlation with Diabetic Complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900263-4

Methylglyoxal, glyoxalases and the development of diabetic complications.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900263-4

Immunological evidence for methylglyoxal-derived modifications in vivo. Determination of antigenic epitopes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900263-4

The reaction of methylglyoxal with aminoguanidine under physiological conditions and prevention of methylglyoxal binding to plasma proteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900263-4

The reaction of some dicarbonyl sugars with aminoguanidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900263-4

Aminoguanidine: a drug proposed for prophylaxis in diabetes inhibits catalase and generates hydrogen peroxide in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900263-4

Metformin-insulin interactions: from organ to cell

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900263-4

Detection of D-glucose-derived pyrrole compounds during Maillard reaction under physiological conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900263-4

Protein modification by methylglyoxal: chemical nature and synthetic mechanism of a major fluorescent adduct

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900263-4

Free radicals generated during the glycation reaction of amino acids by methylglyoxal. A model study of protein-cross-linked free radicals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900263-4

Role of oxidative stress in diabetic complications: a new perspective on an old paradigm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900263-4

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900263-4

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900263-4

Metformin reduces systemic methylglyoxal levels in type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900263-4

10.1016/S0006-2952(99)00263-4

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10571251%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference